TuesdayMay 05, 2020 11:28 am

QualityStocksNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Achieves Record-Breaking Sales in April

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that the company achieved record sales during the last week of April. The company reported a significant increase in sales for the month of April, with numbers climbing more than 800% higher than the average monthly totals seen in calendar Q1. NUGS recently doubled its production capacity, enabling the company to continue to take on growing distributor relationships and larger orders in the California cannabis market. “The close of April represents an important signal in terms of business context. We have seen a number of…

Continue Reading

TuesdayMay 05, 2020 11:09 am

QualityStocksNewsBreaks – SinglePoint, Inc.’s (SING) Hemp Vertical on Track to Double Sales in Q2 Alongside Launch of 1606 Countertop Display

SinglePoint (OTCQB: SING) announced today that it is starting its second quarter with strong numbers and the focus on continued growth. According to the update, SinglePoint’s Hemp vertical is on track to double sales in Q2 alongside the launch of 1606 Hemp six-pack counter top display. 1606 Hemp has seen a 133% increase in sales growth this quarter, as well as a 233% growth in sales up to this point of the month compared to the same timeframe in the previous month.  SinglePoint has placed a focus on self-generated in store placement by hiring professional sales representatives to acquire new…

Continue Reading

TuesdayMay 05, 2020 10:34 am

QualityStocksNewsBreaks – Cannabis Global, Inc. (MCTC) Enters Game-Changing Agreement for Expansion in the California Cannabis Edibles and Beverages Marketplace

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced its entry into a definitive, five-year agreement (the "Agreement") for the production of cannabis edibles and beverages in conjunction with licensed California cannabis operator, Magnolia Extracts, LLC of Lynwood, California. Under the Agreement, Cannabis Global will provide access to its trade secrets and patent pending technologies for chemical-free cannabis and hemp infusions in the production of edibles and beverages containing tetrahydrocannabinol (“THC”). "This deal represents an enormous escalation in terms of our positioning in the California cannabis edibles and beverages marketplace,"…

Continue Reading

TuesdayMay 05, 2020 10:26 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Oncology Franchise via Exclusive Worldwide Patent and Technology License Agreement

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it has entered into a patent and technology license agreement with The University of Texas MD Anderson Cancer Center, granting Genprex an exclusive worldwide license to a portfolio of 16 patent applications and related technology (“Licensed IP”) for the treatment of cancer using Genprex’s lead drug candidate and TUSC2 gene therapy, known as “Oncoprex” or “GEN-001,” in combination with immunotherapies. The Licensed IP covers the use of Oncoprex in combination with one or more immunotherapies for the treatment of…

Continue Reading

TuesdayMay 05, 2020 10:10 am

QualityStocksNewsBreaks – Sharing Services Global Corporation (SHRG) Appoints Global Business Leader to its Board of Directors

Sharing Services Global Corporation (OTCQB: SHRG), formerly Sharing Services Inc., on Monday announced the appointment of Chan Heng Fai Ambrose to serve on its board of directors (the “Board”) as a Class II Director to serve until the annual meeting of shareholders in 2023, or until his successor is elected and qualified. According to the update, the appointment fills a vacancy created by the recently announced resignation of Kip H. Allison from the Board. “We are pleased to have Mr. Chan join the Board and look forward to the variety and depth of experience he brings to the Board,” John…

Continue Reading

TuesdayMay 05, 2020 9:32 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Reveals Plan to Change Company Name to Availa Bio Upon Completion of Cannaworx, SkinScience Transactions

Pressure BioScience (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its plan to change the company’s name to Availa Bio upon completion of the acquisitions and merger of Cannaworx, Inc. and SkinScience Labs, Inc. The three companies will function as synergistic divisions within the combined "Availa Bio" entity, which will focus on optimizing bioavailability, absorption, quality and performance of human, animal and agricultural products. “PBI's UST platform offers the potential to deliver an extraordinary…

Continue Reading

MondayMay 04, 2020 3:30 pm

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) to Launch First-of-Its-Kind Campaign to Offer Virtual-Transaction Platform Across the US

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) today announced its launch of an innovative digital advertising campaign to offer its virtual-transaction platform to consumers and automotive dealers across the United States. The platform allows customers to buy, sell, lease, auction and finance vehicles from any location they choose, including directly within any form of video content. PowerBand, one of the leaders in the digital transformation of the automotive retail industry, has partnered with Source Digital, a pioneer in immersive commerce, through the use of video content on the internet and digital media platforms. The first-of-a-kind campaign will use Source's…

Continue Reading

MondayMay 04, 2020 3:12 pm

QualityStocksNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Announces Leadership Changes

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, today announced its appointment of Mark K. Ruport as president and chief executive officer. According to the update, Ruport will continue to serve as a member of the Board of Directors and, as part of the transition, John Rice has stepped aside from his position as president and CEO and will continue in his role as the non-executive chairman of the Board of Directors of Sigma Labs. "John Rice has been instrumental in our development efforts, bringing Sigma Labs from a pre-commercial company to…

Continue Reading

MondayMay 04, 2020 2:52 pm

QualityStocksNewsBreaks – Youngevity International, Inc.’s (NASDAQ: YGYI) Khrysos Industries Launches Business- and Consumer-Facing Web Interface for FDA-Approved Hand Sanitizers

Youngevity International (NASDAQ: YGYI), together with its wholly owned subsidiary, Khrysos Industries, Inc., today announced the launch of a web interface dedicated for the sale of the company's new line of hand sanitizers. The landing page (www.Khrysos-HandSanitizer.com) targets both businesses and consumers and can be accessed for immediate purchase. "We began shipping hand sanitizer on April 7 and we are pleased to be a part of the solution for a product that remains in short supply," Dave Briskie, President and CFO of YGYI, stated in the news release. "This web interface should provide seamless access to our customers for information…

Continue Reading

MondayMay 04, 2020 2:20 pm

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Issues Shareholder Letter Highlighting Oncoprex(TM) Progress, License Agreement for a Diabetes Drug Candidate and Other Achievements

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced its issuance of an April 2020 Shareholder Letter. According to the update, the letter highlights the Company’s progress with Oncoprex(TM), its lead drug candidate with an initial targeted indication for non-small cell lung cancer (“NSCLC”), its license agreement for a diabetes gene therapy drug candidate, as well as other operational and business achievements. A digital copy of the letter can be found on the Company’s website. To view the full press release, visit http://ibn.fm/DyN7C About Genprex, Inc. Genprex, Inc. is…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered